![N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide](https://static.cymitquimica.com/products/3D/img/EQB75796.png "Cliccare per ingrandire")
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS: 1004757-96-3
Rif. 3D-EQB75796
| 100mg | Prezzo su richiesta | |
| 250mg | Prezzo su richiesta |
Informazioni sul prodotto
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune and inflammatory diseases. It inhibits tumor necrosis factor alpha (TNFα), which is a cytokine involved in the immune response, leading to decreased inflammation. NAPQI also has the ability to inhibit the production of macrophage chemotactic protein 1 (MCP1), which is a chemokine involved in the inflammatory process. NAPQI can be used as a prodrug and modulates receptor activity by binding to TNFα, leading to reduced inflammation.
Proprietà chimiche
Richiesta tecnica su: 3D-EQB75796 N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
